☰

Gene G. Olinger, Ph.D. - Publications

Affiliations: 
2001 Rush University, Chicago, IL, United States 
Area:
Microbiology Biology, Immunology
Tree Info Similar researchers PubMed Report error

50 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bruchez A, Sha K, Johnson J, Chen L, Stefani C, McConnell H, Gaucherand L, Prins R, Matreyek KA, Hume AJ, Mühlberger E, Schmidt EV, Olinger GG, Stuart LM, Lacy-Hulbert A. MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses. Science (New York, N.Y.). PMID 32855215 DOI: 10.1126/Science.Abb3753  0.331
2019 Logue J, Vargas Licona W, Cooper TK, Reeder B, Byrum R, Qin J, Deiuliis Murphy N, Cong Y, Bonilla A, Sword J, Weaver W, Kocher G, Olinger GG, Jahrling PB, Hensley LE, et al. Ebola Virus Isolation Using Huh-7 Cells has Methodological Advantages and Similar Sensitivity to Isolation Using Other Cell Types and Suckling BALB/c Laboratory Mice. Viruses. 11. PMID 30781518 DOI: 10.3390/v11020161  0.306
2018 Dyall J, Johnson JC, Hart BJ, Postnikova E, Cong Y, Zhou H, Gerhardt DM, Michelotti J, Honko AN, Kern S, DeWald LE, O'Loughlin KG, Green CE, Mirsalis JC, Bennett RS, ... Olinger GG, et al. In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus. The Journal of Infectious Diseases. PMID 30016444 DOI: 10.1093/infdis/jiy345  0.312
2018 Luke T, Bennett RS, Gerhardt DM, Burdette T, Postnikova E, Mazur S, Honko AN, Oberlander N, Byrum R, Ragland D, St Claire M, Janosko KB, Smith G, Glenn G, Hooper J, ... ... Olinger GG, et al. Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate. The Journal of Infectious Diseases. PMID 30010950 DOI: 10.1093/Infdis/Jiy377  0.392
2017 Bennett RS, Huzella LM, Jahrling PB, Bollinger L, Olinger GG, Hensley LE. Nonhuman Primate Models of Ebola Virus Disease. Current Topics in Microbiology and Immunology. PMID 28643203 DOI: 10.1007/82_2017_20  0.321
2017 Lennemann NJ, Herbert AS, Brouillette R, Rhein B, Bakken RA, Perschbacher KJ, Cooney AL, Miller-Hunt CL, Ten Eyck P, Biggins J, Olinger G, Dye JM, Maury W. Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice. Journal of Virology. PMID 28615211 DOI: 10.1128/Jvi.00479-17  0.305
2017 Nelson EA, Dyall J, Hoenen T, Barnes AB, Zhou H, Liang JY, Michelotti J, Dewey WH, DeWald LE, Bennett RS, Morris PJ, Guha R, Klumpp-Thomas C, McKnight C, Chen YC, ... ... Olinger GG, et al. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection. Plos Neglected Tropical Diseases. 11: e0005540. PMID 28403145 DOI: 10.1371/Journal.Pntd.0005540  0.366
2016 Cong Y, Dyall J, Hart BJ, DeWald LE, Johnson JC, Postnikova E, Zhou H, Gross R, Rojas O, Alexander I, Josleyn N, Zhang T, Michelotti J, Janosko K, Glass PJ, ... ... Olinger GG, et al. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus. Plos One. 11: e0166318. PMID 27902714 DOI: 10.1371/Journal.Pone.0166318  0.39
2016 Johnson RF, Bagci U, Keith L, Tang X, Mollura DJ, Zeitlin L, Qin J, Huzella L, Bartos CJ, Bohorova N, Bohorov O, Goodman C, Kim DH, Paulty MH, Velasco J, ... ... Olinger GG, et al. 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012. Virology. 490: 49-58. PMID 26828465 DOI: 10.1016/J.Virol.2016.01.004  0.339
2015 Kugelman JR, Kugelman-Tonos J, Ladner JT, Pettit J, Keeton CM, Nagle ER, Garcia KY, Froude JW, Kuehne AI, Kuhn JH, Bavari S, Zeitlin L, Dye JM, Olinger GG, Sanchez-Lockhart M, et al. Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail. Cell Reports. 12: 2111-20. PMID 26365189 DOI: 10.1016/J.Celrep.2015.08.038  0.437
2015 Fusco ML, Hashiguchi T, Cassan R, Biggins JE, Murin CD, Warfield KL, Li S, Holtsberg FW, Shulenin S, Vu H, Olinger GG, Kim DH, Whaley KJ, Zeitlin L, Ward AB, et al. Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs. Plos Pathogens. 11: e1005016. PMID 26115029 DOI: 10.1371/Journal.Ppat.1005016  0.332
2015 O'Hearn A, Wang M, Cheng H, Lear-Rooney CM, Koning K, Rumschlag-Booms E, Varhegyi E, Olinger G, Rong L. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry. Journal of Virology. 89: 5441-9. PMID 25741008 DOI: 10.1128/Jvi.03689-14  0.383
2015 Hensley LE, Dyall J, Olinger GG, Jahrling PB. Lack of effect of lamivudine on Ebola virus replication. Emerging Infectious Diseases. 21: 550-2. PMID 25695153 DOI: 10.3201/eid2103.141862  0.327
2014 Murin CD, Fusco ML, Bornholdt ZA, Qiu X, Olinger GG, Zeitlin L, Kobinger GP, Ward AB, Saphire EO. Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proceedings of the National Academy of Sciences of the United States of America. 111: 17182-7. PMID 25404321 DOI: 10.1073/Pnas.1414164111  0.306
2014 Garrison AR, Giomarelli BG, Lear-Rooney CM, Saucedo CJ, Yellayi S, Krumpe LR, Rose M, Paragas J, Bray M, Olinger GG, McMahon JB, Huggins J, O'Keefe BR. The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus. Antiviral Research. 112: 1-7. PMID 25265598 DOI: 10.1016/J.Antiviral.2014.09.012  0.374
2014 Johnson JC, Martinez O, Honko AN, Hensley LE, Olinger GG, Basler CF. Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells. Antiviral Research. 107: 102-9. PMID 24815087 DOI: 10.1016/J.Antiviral.2014.04.014  0.427
2014 Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, ... ... Olinger GG, et al. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Archives of Virology. 159: 1229-37. PMID 24190508 DOI: 10.1007/S00705-013-1877-2  0.407
2013 Pettitt J, Zeitlin L, Kim do H, Working C, Johnson JC, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly MH, Whaley KJ, Ingram MF, Zovanyi A, ... ... Olinger GG, et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Science Translational Medicine. 5: 199ra113. PMID 23966302 DOI: 10.1126/scitranslmed.3006608  0.321
2013 Johansen LM, Brannan JM, Delos SE, Shoemaker CJ, Stossel A, Lear C, Hoffstrom BG, Dewald LE, Schornberg KL, Scully C, Lehár J, Hensley LE, White JM, Olinger GG. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Science Translational Medicine. 5: 190ra79. PMID 23785035 DOI: 10.1126/Scitranslmed.3005471  0.301
2013 Reed C, Lin K, Wilhelmsen C, Friedrich B, Nalca A, Keeney A, Donnelly G, Shamblin J, Hensley LE, Olinger G, Smith DR. Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development. Plos Neglected Tropical Diseases. 7: e2156. PMID 23593523 DOI: 10.1371/Journal.Pntd.0002156  0.344
2013 Brudner M, Karpel M, Lear C, Chen L, Yantosca LM, Scully C, Sarraju A, Sokolovska A, Zariffard MR, Eisen DP, Mungall BA, Kotton DN, Omari A, Huang IC, Farzan M, ... ... Olinger GG, et al. Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors. Plos One. 8: e60838. PMID 23573288 DOI: 10.1371/Journal.Pone.0060838  0.647
2013 Shoemaker CJ, Schornberg KL, Delos SE, Scully C, Pajouhesh H, Olinger GG, Johansen LM, White JM. Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. Plos One. 8: e56265. PMID 23441171 DOI: 10.1371/Journal.Pone.0056265  0.339
2013 Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, ... ... Olinger GG, et al. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Archives of Virology. 158: 1425-32. PMID 23358612 DOI: 10.1007/S00705-012-1594-2  0.358
2013 Martinez O, Johnson JC, Honko A, Yen B, Shabman RS, Hensley LE, Olinger GG, Basler CF. Ebola virus exploits a monocyte differentiation program to promote its entry. Journal of Virology. 87: 3801-14. PMID 23345511 DOI: 10.1128/Jvi.02695-12  0.388
2013 Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Hensley LE, Honko AN, Jahrling PB, ... ... Olinger GG, et al. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Archives of Virology. 158: 301-11. PMID 23001720 DOI: 10.1007/S00705-012-1454-0  0.351
2012 Friedrich BM, Trefry JC, Biggins JE, Hensley LE, Honko AN, Smith DR, Olinger GG. Potential vaccines and post-exposure treatments for filovirus infections. Viruses. 4: 1619-50. PMID 23170176 DOI: 10.3390/V4091619  0.324
2012 Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America. 109: 18030-5. PMID 23071322 DOI: 10.1073/Pnas.1213709109  0.419
2011 Warfield KL, Olinger GG. Protective Role of Cytotoxic T Lymphocytes in Filovirus Hemorrhagic Fever Biomed Research International. 2011: 984241-984241. PMID 22253531 DOI: 10.1155/2011/984241  0.441
2011 Sullivan NJ, Hensley L, Asiedu C, Geisbert TW, Stanley D, Johnson J, Honko A, Olinger G, Bailey M, Geisbert JB, Reimann KA, Bao S, Rao S, Roederer M, Jahrling PB, et al. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nature Medicine. 17: 1128-31. PMID 21857654 DOI: 10.1038/Nm.2447  0.428
2011 Michelow IC, Lear C, Scully C, Prugar LI, Longley CB, Yantosca LM, Ji X, Karpel M, Brudner M, Takahashi K, Spear GT, Ezekowitz RA, Schmidt EV, Olinger GG. High-dose mannose-binding lectin therapy for Ebola virus infection. The Journal of Infectious Diseases. 203: 175-9. PMID 21288816 DOI: 10.1093/Infdis/Jiq025  0.642
2010 Michelow IC, Dong M, Mungall BA, Yantosca LM, Lear C, Ji X, Karpel M, Rootes CL, Brudner M, Houen G, Eisen DP, Kinane TB, Takahashi K, Stahl GL, Olinger GG, et al. A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. The Journal of Biological Chemistry. 285: 24729-39. PMID 20516066 DOI: 10.1074/Jbc.M110.106260  0.556
2010 Smith DR, McCarthy S, Chrovian A, Olinger G, Stossel A, Geisbert TW, Hensley LE, Connor JH. Inhibition of heat-shock protein 90 reduces Ebola virus replication. Antiviral Research. 87: 187-94. PMID 20452380 DOI: 10.1016/J.Antiviral.2010.04.015  0.412
2010 Martinez O, Johnson J, Manicassamy B, Rong L, Olinger GG, Hensley LE, Basler CF. Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cellular Microbiology. 12: 148-57. PMID 19775255 DOI: 10.1111/J.1462-5822.2009.01385.X  0.315
2009 Kinch MS, Yunus AS, Lear C, Mao H, Chen H, Fesseha Z, Luo G, Nelson EA, Li L, Huang Z, Murray M, Ellis WY, Hensley L, Christopher-Hennings J, Olinger GG, et al. FGI-104: a broad-spectrum small molecule inhibitor of viral infection. American Journal of Translational Research. 1: 87-98. PMID 19966942 DOI: 10.1016/J.Antiviral.2009.02.082  0.354
2009 Kalina WV, Warfield KL, Olinger GG, Bavari S. Discovery of common marburgvirus protective epitopes in a BALB/c mouse model. Virology Journal. 6: 132. PMID 19712478 DOI: 10.1186/1743-422X-6-132  0.426
2008 Anzinger JJ, Olinger GG, Spear GT. Donor variability in HIV binding to peripheral blood mononuclear cells. Virology Journal. 5: 95. PMID 18706090 DOI: 10.1186/1743-422X-5-95  0.681
2007 Warfield KL, Alves DA, Bradfute SB, Reed DK, VanTongeren S, Kalina WV, Olinger GG, Bavari S. Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virology Journal. 4: 108. PMID 17961252 DOI: 10.1186/1743-422X-4-108  0.376
2007 Warfield KL, Swenson DL, Olinger GG, Kalina WV, Aman MJ, Bavari S. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. The Journal of Infectious Diseases. 196: S430-7. PMID 17940980 DOI: 10.1086/520583  0.329
2007 Warfield KL, Swenson DL, Olinger GG, Kalina WV, Viard M, Aitichou M, Chi X, Ibrahim S, Blumenthal R, Raviv Y, Bavari S, Aman MJ. Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent. The Journal of Infectious Diseases. 196: S276-83. PMID 17940961 DOI: 10.1086/520605  0.306
2006 Mohamadzadeh M, Chen L, Olinger GG, Pratt WD, Schmaljohn AL. Filoviruses and the balance of innate, adaptive, and inflammatory responses. Viral Immunology. 19: 602-12. PMID 17201655 DOI: 10.1089/Vim.2006.19.602  0.342
2006 Mohamadzadeh M, Coberley SS, Olinger GG, Kalina WV, Ruthel G, Fuller CL, Swenson DL, Pratt WD, Kuhns DB, Schmaljohn AL. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses. Journal of Virology. 80: 7235-44. PMID 16809329 DOI: 10.1128/Jvi.00543-06  0.421
2006 Warfield KL, Swenson DL, Olinger GG, Nichols DK, Pratt WD, Blouch R, Stein DA, Aman MJ, Iversen PL, Bavari S. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. Plos Pathogens. 2: e1. PMID 16415982 DOI: 10.1371/Journal.Ppat.0020001  0.372
2005 Olinger GG, Bailey MA, Dye JM, Bakken R, Kuehne A, Kondig J, Wilson J, Hogan RJ, Hart MK. Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins. Journal of Virology. 79: 14189-96. PMID 16254354 DOI: 10.1128/Jvi.79.22.14189-14196.2005  0.466
2005 Ji X, Olinger GG, Aris S, Chen Y, Gewurz H, Spear GT. Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. The Journal of General Virology. 86: 2535-42. PMID 16099912 DOI: 10.1099/Vir.0.81199-0  0.658
2002 Olinger GG, Saifuddin M, Hart ML, Spear GT. Cellular factors influence the binding of HIV type 1 to cells. Aids Research and Human Retroviruses. 18: 259-67. PMID 11860673 DOI: 10.1089/088922202753472838  0.665
2001 Spear GT, Hart M, Olinger GG, Hashemi FB, Saifuddin M. The role of the complement system in virus infections. Current Topics in Microbiology and Immunology. 260: 229-45. PMID 11443876  0.62
2001 Spear GT, Olinger GG, Saifuddin M, Gebel HM. Human antibodies to major histocompatibility complex alloantigens mediate lysis and neutralization of HIV-1 primary isolate virions in the presence of complement. Journal of Acquired Immune Deficiency Syndromes (1999). 26: 103-10. PMID 11242176 DOI: 10.1097/00042560-200102010-00001  0.651
2000 Olinger GG, Saifuddin M, Spear GT. CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells. Journal of Virology. 74: 8550-7. PMID 10954556 DOI: 10.1128/Jvi.74.18.8550-8557.2000  0.617
1999 Olinger GG, Hashemi FB, Sha BE, Spear GT. Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1. Aids (London, England). 13: 1905-12. PMID 10513649 DOI: 10.1097/00002030-199910010-00013  0.572
1999 Al-Harthi L, Roebuck KA, Olinger GG, Landay A, Sha BE, Hashemi FB, Spear GT. Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. Journal of Acquired Immune Deficiency Syndromes (1999). 21: 194-202. PMID 10421242 DOI: 10.1097/00126334-199907010-00003  0.634
Show low-probability matches.